Sign Up Today and Learn More About Ancora Heart Stock
Invest in or calculate the value of your shares in Ancora Heart or other pre-IPO companies through EquityZen's platform.

Ancora Heart Stock (ANHA)
Ancora Heart is dedicated to helping people with heart failure feel better and live longer.
About Ancora Heart Stock
Founded
2001
Headquarters
Santa Clara, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Ancora Heart is dedicated to helping people with heart failure feel better and live longer. Ancora Heart developed the AccuCinch System, an investigational therapy designed to repair the enlarged left ventricle targeting the underlying cause of heart failure. The AccuCinch heart failure treatment was created to benefit the millions of patients who otherwise have no minimally invasive option available to them.
Ancora Heart Press Mentions
Stay in the know about the latest news on Ancora Heart
Systems and methods for deploying devices into cardiac tissue
patents • Feb 09, 2025
Device and method for releasing catheters from cardiac structures
patents • Feb 09, 2025
Ohio State First in Central Ohio to Use Novel Heart Failure Therapy
dicardiology • May 05, 2024
Myocardial implant load sharing device and methods to promote LV function
patents • Apr 14, 2024
Device and method for releasing catheters from cardiac structures
patents • Apr 14, 2024
Ancora Heart Management
Leadership team at Ancora Heart
Board Observer
Naveen Yalamanchi
President and CEO
Jeffrey M. Closs

Join now and verify your accreditation status to gain access to:
- Ancora Heart Current Valuation
- Ancora Heart Stock Price
- Ancora Heart Management
- Available deals in Ancora Heart and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ancora Heart Cap Table and Funding History by Share Class and Liquidity Preferences
- Ancora Heart Revenue and Financials
- Ancora Heart Highlights
- Ancora Heart Business Model
- Ancora Heart Risk Factors
- Ancora Heart Research Report from SACRA Research
Trading Ancora Heart Stock
How to invest in Ancora Heart stock?
Accredited investors can buy pre-IPO stock in companies like Ancora Heart through EquityZen funds. These investments are made available by existing Ancora Heart shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ancora Heart stock?
Shareholders can sell their Ancora Heart stock through EquityZen's private company marketplace. EquityZen's network includes over 350K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."